Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis
Clinical Endoscopy. 2019;52(5):502-505 
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer patients who have a potential risk of lymph node metastasis
Gastrointestinal Endoscopy. 2011;74(4):792-797
Risk of lymph node metastasis and feasibility of endoscopic submucosal dissection in undifferentiated-type early gastric cancer
BMC Gastroenterology. 2023;23(1):
Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
Cancers. 2021;13(5):983
RA04.05: PREVALENCE OF LYMPH-NODE METASTASIS IN T1B ESOPHAGEAL SQUAMOUS CELL CANCER: IMPLICATIONS FOR ADDITIONAL RADIOTHERAPY DESIGN FOLLOWING ENDOSCOPIC SUBMUCOSAL DISSECTION
Diseases of the Esophagus. 2018;31(Supplement_1):26-26
Risk Factors and Prognostic Significance of Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Patients with Clinically Suspected Lateral Lymph Node Metastasis
. 2021;
Sa1580 Risk of Lymph Node Metastasis in Undifferentiated Mixed Type Early Gastric Cancer and the Feasibility of Endoscopic Submucosal Dissection
Gastrointestinal Endoscopy. 2013;77(5):AB257
Endoscopic Submucosal Dissection for Superficial Esophageal Cancer
Endoscopic Submucosal Dissection. 2015;85-94
Tu1486 LOW FREQUENCY OF LYMPH NODE METASTASIS IN ABSOLUTE, BUT NOT EXPANDED, INDICATIONS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION OF EARLY GASTRIC CANCER IN US PATIENTS
Gastrointestinal Endoscopy. 2020;91(6):AB584-AB585
Esophageal endoscopic submucosal dissection using a novel thin therapeutic scope for early esophageal cancer adjacent to chemoradiotherapy-induced stricture
Endoscopy. 2023;55(S 01):E581-E582